Details of the Drug

General Information of Drug (ID: DMYDMVI)

Drug Name
SGT-001
Indication
Disease Entry ICD 11 Status REF
Duchenne dystrophy 8C70 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0AN3N

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)